Benchling Solutions Delivery Manager Andrew Mecca shares why antibody therapeutics are on the rise and how companies are leveraging Benchling’s technology to handle the complexity of modern antibody R&D.
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders.
Benchling Solutions Delivery Manager Andrew Mecca shares why antibody therapeutics are on the rise and how companies are leveraging Benchling’s technology to handle the complexity of modern antibody R&D.